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In this work, we present two different applications of microfluidic control. In the first 
application, we have developed a microfluidic device that has the potential to 
automate combinatorial protocols like protein refolding, impacting the 
biopharmaceutical industry. This device uses microfluidic valves and pumps that can 
be operated in an automated fashion for fluidic control. We performed refolding 
experiments on the protein β-galactosidase and showed on-chip quantification of 
refolding yield using a fluorometric assay. In the second application, we have 
developed a microfluidic immunobiosensor with an integrated preconcentration 
system to improve the detection sensitivity. A nanoporous membrane fabricated in-situ 
using photopolymerization technique inside glass microchannels acts as the 
preconcentration system. Analytes were electrophoretically concentrated at the 
membrane and the concentrated bolus was eluted towards a detection region 
downstream. We performed proof-of-principle experiments using biotin-streptavidin 
binding to show the improvement in detection sensitivity of this device as opposed to 
a device that does not include a preconcentration system. Using this device, we also 
showed a detection limit of 1.6 X 10
5
 PFU/ml for Feline Calicivirus (FCV), which is a 
model system for human enteric virus. This device has potential to serve as an early 
detection system for such enteric viruses in environmental water samples.
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1 
CHAPTER 1 
INTRODUCTION 
 
 
In this work, we present two different applications of microfluidic control. In the first 
application, fluidic injection and mixing is controlled by valves and pumps and this 
device is used for automating combinatorial protocols like protein refolding. The 
rotary mixer used in this device helps to overcome the long mixing times characteristic 
of microfluidic flows which are low Reynolds number and high Peclet number flows. 
In the second application, fluidic control is achieved using electric fields in 
conjunction with a nanoporous membrane to concentrate analytes and this is combined 
with a downstream detection system. The application of this device is to detect the 
presence of viruses in water samples.  The electrophoretic preconcentration used in 
this device helps to improve the limit of detection of the integrated biosensor. 
 
 
1.1 Refolding of β-galactosidase in a microfluidic device 
 
1.1.1 Production of recombinant proteins in the biopharmaceutical industry 
 
In the biopharmaceutical industry, bacterial genome is manipulated using recombinant 
DNA technology to produce pharmacologically useful peptides like the human insulin 
polypeptides [1]. Bacterial systems like E. coli are commonly used as hosts for the 
production of such recombinant proteins [2]. To overexpress the production of 
recombinant proteins, these bacteria are induced using reagents like isopropyl β-D-
thiogalactopyranoside, which is an inducer of the lac promoter [3]. This over-
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expression leads to the formation of misfolded protein aggregates called inclusion 
bodies [4]. Aggregation of proteins into inclusion bodies maybe due to the limiting 
amounts of molecular chaperones (needed to properly refold proteins to their native 
state) in such over-expressed systems [5]. When non-physiological amounts of 
proteins are produced, the aggregation of the folding intermediates occurs due to 
interaction of the exposed hydrophobic surfaces before protein folding is completed. 
The formation of inclusion bodies is a bottleneck in protein production as the refolding 
protocols to convert the non-functional inclusion bodies to their functional native state 
are complex. The solution conditions, like buffers and the right pH conditions, to 
properly refold proteins are not known a priori and choosing these solution conditions 
is a highly empirical process.  
 
1.1.2 Protein refolding 
 
The process of refolding refers to the conversion of the misfolded protein aggregates 
or inclusion bodies into the folded native state. The native and functional three-
dimensional structure of a protein under a given set of conditions (solvent, pH, ionic 
strength, temperature etc.) is determined by its amino acid sequence (or the primary 
structure) [6]. This native state also corresponds to the one for which the Gibbs free 
energy of the system is the lowest [6]. In the folded state, proteins have their nonpolar 
side chains buried in the interior, which constitutes the hydrophobic core, while the 
polar groups occupy the solvent-exposed surface, constituting the hydrophilic exterior. 
The formation of intramolecular hydrogen bonds and disulphide linkages further 
enhances the stability of the protein. These various interactions like hydrophobic 
effects, hydrogen bonds and disulphide linkages drive the folding mechanism of the 
protein, collapsing it  to its native state [7].   
 3 
 
The main challenge in refolding proteins is the competing kinetics between 
aggregation and refolding [8]. Aggregation is a strong function of the initial protein 
concentration. As a result, refolding is performed in a renaturing medium at very high 
dilutions. The first step in the refolding protocol involves solubilizing the inclusion 
bodies into individual protein strands using strong denaturants like 6M guanidinium 
chloride or 6-8M urea. These reagents are strong chaotrophs, which shield the charged 
groups of the proteins and disrupt the stabilizing intramolecular interactions like 
hydrogen bonds and hydrophobic effects, thereby solubilizing the aggregated proteins. 
The solubilized proteins are then diluted in a renaturing medium which contains 
various artificial chaperones which are chemicals which help to properly refold the 
individual protein strands into their native state, while keeping them solubilized. 
Examples of these artificial chaperones include non-denaturing concentrations of 
chaotrophs (which prevent hydrophobic interactions between folding intermediates), 
zwitterionic detergents and different salts. Selecting the right combination of these 
chaperones is a combinatorial process  [9].  
We performed refolding experiments on the protein β-galactosidase, which is 
an essential enzyme in the human body that catalyzes the hydrolysis of β-galactosides 
like lactose. β-Galactosidase is a tetrameric enzyme which consists of four identical 
subunits [10-12]. Denaturation of the protein in 8M urea results in complete loss of 
secondary structure, resulting in the formation of unfolded monomer subunits. When 
the denatured protein is then refolded by diluting it in a renaturing medium (1.4 M 
urea, 0.1 M sodium phosphate, 1 mM magnesium chloride, 5 mM DTE) , the first step 
is the formation of folded monomer units, which occurs very quickly. The monomers 
then associate to form dimers. This is the first rate-limiting step during the refolding 
process while the structural rearrangement of the dimers is the second rate-limiting 
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step. The final step which is the association of the dimers to tetramer is again a fast 
step [13].  
   
1.1.3 Microfluidic devices for protein refolding 
 
Choosing the right solution conditions for protein refolding is an empirical process 
and is done conventionally using hand-pipeting on a small scale or using robotic 
systems on a large scale. However, hand-pipeting is labor-intensive while robotic 
systems are expensive. Microfluidic systems offer several advantages for such 
combinatorial processes over conventional techniques, like usage of small sample 
volumes, cost-effectiveness and automation. Several microfluidic devices have been 
developed by different groups for protein processing and high throughput applications. 
Zheng et al. [14] have developed a two-phase droplet-based system for protein 
crystallization application. Although this design is capable of high throughput 
combinatorial processing [15], it is limited by the dependence of droplet formation on 
solution viscosity [16]. Reagents like surfactants are not easy to introduce into the 
aqueous droplet as they tend to stabilize the interface of the two-phase system. 
Another technique that has gained importance in such applications is the technique of 
electrowetting-on-dielectric to digitally address droplets [17, 18]. However, the 
limitations of this system are that the biological samples adhere to the hydrophobic 
dielectric surface [19]. Also, there are challenges associated with actuating non- 
aqueous droplets with this system [20]. Other examples of microfluidic devices for 
protein processing applications include devices made by Hansen et al. [21] that use 
free interface diffusion for protein crystallization and those made by Kerby et al. [22] 
that use fluorescent dyes that bind to exposed hydrophobic regions of a protein to 
make kinetic measurements of protein conformation. 
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On the other hand, Unger et al. [23] have demonstrated the use of pneumatic 
valves and pumps in microfluidic device to control flow in an automated fashion and 
Thorsen et al. [24] have shown the use of a microfluidic multiplexor for large scale 
integration using minimum number of actuation channels. These systems are 
independent of the type of solutions used in the device as the actuation is mechanical. 
We use similar pneumatic valves and pumps in our design of the microfluidic device 
for combinatorial protein refolding. Also, we use a rotary mixer for mixing the 
different reagents in our device as it is simple to fabricate and uses very small sample 
volumes as opposed to staggered-herringbone mixers [25] which involve complex 
two-step etching process to fabricate and serpentine channels [26] which utilize larger 
sample volumes.  
In Chapter 2, we show the use of our PDMS-glass microfluidic device in 
automating combinatorial protocols. Our device consists of three input channels for 
selecting reagents, a rotary mixer for mixing the denatured protein with the selected 
reagents and an output channel to quantify the refolding yield of the protein. We 
performed specific experiments to show the ability of our device to precisely control 
sample volumes during injection and to efficiently mix reagents in the rotary mixer. 
We performed refolding experiments on the protein β-galactosidase and quantified the 
refolding yield using a fluorometric assay [27]. We showed on-chip quantification of 
refolding yields using this assay on our microfluidic device, showing the potential for 
our device to be used in protein refolding applications. 
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1.2 Development of antibody-based microfluidic biosensors for environmental 
water sampling 
 
1.2.1 Enteric viruses in environmental water samples 
 
Enteric viruses are viruses that inhabit and replicate in the gastrointestinal tract and 
cause various gastrointestinal illnesses. Infected humans or host animals shed these 
virus particles in feces and these are introduced into water bodies through leaking 
sewage and septic systems and urban run-off systems [28]. These viruses can be 
transmitted to other individuals and animals by the water route. The United States 
Environmental Protection Agency (USEPA) maintains a list of waterborne pathogens 
called the Contaminant Candidate List (CCL) to identify unregulated pathogens for 
which more information is needed before a regulatory determination can be made. 
Detection of enteric viruses like adenovirus, calicivirus, enterovirus etc. in 
environmental water bodies is of particular importance to the EPA as these viruses fall 
under the CCL. Knowing the type and concentration of these viruses in source water 
helps to design the right water treatment method to prevent disease outbreak. 
 
1.2.2 Detection of enteric viruses 
 
The detection of enteric viruses in environmental waters requires the ability to process 
large volumes of water, on the order of hundreds of liters, as these pathogens are 
present in very concentrations [29].  Conventionally, this is done using electropositive 
ceramic cartridge filters like 1 MDS and NanoCeram filters, which have high recovery 
efficiencies and can reduce the sample volumes from hundreds of liters to a few 
milliliters [30-32]. This concentrated sample is then sent for detection which is 
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generally done using one of two methods – cell culture methods and molecular 
methods [33]. In cell culture methods, a monolayer of cells is infected with the viral 
sample and the number of visible plaques is counted to determine water quality. These 
methods also give information on the infectivity of viruses [34]. However, they are 
very time-intensive as they take several days or weeks to culture the cells and also 
require skilled labor to interpret the results.  On the other hand, molecular methods 
using PCR have become increasingly popular for virus detection as they are not as 
time-consuming as the cell culture methods. They can also be used for detecting 
viruses that cannot be grown on established cell lines. Quantitative reverse 
transcriptase PCR assays using TaqMan probes have been used for the detection of 
various enteric viruses [35] like hepatitis A virus [36, 37], human adenovirus [38] and 
Norwalk-like virus [39]. Although these real-time PCR methods exhibit low limits of 
detection, they are affected by inhibitors (like humic compounds, polysaccharides, 
metal ions etc.) present in environmental water samples resulting in false negatives. 
Hence, the samples need to be excessively processed by different methods like 
dialysis, solvent extraction, ultrafiltration and glass purification, before use in a PCR 
assay [40, 41].  
 Integrated cell culture RT-PCR techniques have been developed to overcome 
the disadvantages associated with conventional cell culture and direct RT-PCR 
techniques. In these methods, the viruses are made to replicate in cell culture for a 
short duration followed by PCR amplification. Reynolds et al. have developed such an 
integrated method for enterovirus detection [42] while adenovirus detection was done 
by Lee et al. [43]. These methods are less time-consuming than conventional cell 
culture methods and also give information on virus infectivity. However, this process 
can decrease the efficiency of detection [44].  
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 Another molecular method used for viral RNA detection is Nucleic Acid 
Sequence Based Amplification (NASBA), which amplifies RNA at a single 
temperature of 41°C. This method does not require thermal cycling between two 
temperatures like in RT-PCR and the time of the overall process is also reduced. 
NASBA has been used in conjunction with molecular beacons for real-time detection 
of hepatitis A virus [45] and norovirus [46] in seeded surface water samples. However, 
synthesis of specific molecular beacon probes for different viruses is expensive. 
Zaytseva et al. [47] developed a microfluidic biosensor with magnetic bead-based 
sandwich hydridization system using fluorescent liposomes for Dengue virus RNA 
detection. This device uses off-chip NASBA for RNA amplification before 
introducing the sample into the biosensor.  
 Apart from cell culture and molecular methods, a number of 
immunobiosensors have been developed for enteric virus detection.  An automated 
portable fiber optic biosensor for MS2 coliphage detection was developed based on a 
fluorescent sandwich immunoassay [48, 49]. Rossi et al. [50] developed a porous 
silicon biosensor with antibodies conjugated on nanoporous silicon films for MS2 
coliphage detection while Pineda et al. [51] developed a photonic crystal biosensor the 
detection of porcine rotavirus. The limits of detection with these biosensors were in 
the range of 10
4
-10
9
 PFU/ml.  
 Atomic force microscopy (AFM) and surface-enhanced raman spectroscopy 
(SERS) have reported limits of detection of 3X10
6
 and 1X10
6
 particles/ml for the 
detection of feline calicivirus (FCV) [52]. However, AFM requires expensive and 
bulky equipment for detection and depends on the rigidity of viral particles while 
SERS uses expensive optical systems.  
 In the portable microfluidic device format, most of the devices that were 
developed for enteric virus detection use RT-PCR techniques [53-55]. Although these 
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techniques have the potential to achieve low limits of detection (10 – 100 PFU/ml), 
they are limited by a number of issues. Apart from the limitation of inhibitors in 
environmental water samples, miniaturizing PCR has a number of challenges like 
adhesion of the enzymes to channel walls [56], difficulty in precisely controlling 
temperatures, sample evaporation and formation of bubbles in channels [57]. 
Miniaturized NASBA systems do not have temperature cycling issues but these 
systems require extensive surface pretreatment to avoid adhesion of the three enzymes 
used during amplification to the channel walls [58, 59].  
 
Table 1.1: Comparison of different techniques for virus detection 
 
Technique Analyte Limit of 
Detection 
Low cost/ 
Portability Time Remarks 
SERS [52]  FCV ~1 X 10
4
 
PFU/ml* 
Portable but 
expensive 
~20 h assay 
time 
Sensitive and 
multiplexed 
analysis 
Fiber optic 
immuno- 
biosensor [49] 
MS2 10
9
 PFU/ml 
Portable but 
expensive 
10 min assay 
time 
Rapid, automated 
detection; High 
limit of detection 
Porous silicon 
immune- 
biosensor [50] 
MS2 
2 X 10
7
 
PFU/ml 
No 
~1h assay 
time 
Interfering photo-
luminescence 
issues 
Photonic crystal 
immune- 
biosensor [51] 
Rotavirus 
1.8 X 10
3
 
PFU/ml 
No 
30 min assay 
time 
Extensive surface 
functionalization; 
single use 
Miniaturized 
integrated  RT-
PCR devices [53, 
55] 
Dengue 
virus [53] 
10
2
 PFU/ml 
 
Yes 
4 h  total time 
 Affected by 
inhibitors; 
temperature 
cycling issues Rotavirus 
[55] 
6.4 X 10
4
 
copies/µl 
Yes 
1 h  RT-PCR 
time 
Microfluidic 
immunobiosensor 
(direct injection) 
FCV 2.4 X 10
6
 
PFU/ml 
Yes 
2 h incubation 
+ 20 min on-
chip detection 
Portable and 
inexpensive with 
EC detection 
Microfluidic 
immunobiosensor  
(preconcentration) 
FCV 1.6 X 10
5
 
PFU/ml 
Yes 
2 h incubation 
+ 20 min on-
chip detection 
Portable and 
inexpensive with 
EC detection 
                    *infectious:non-infectious viruses ~ 1:100 for enteroviruses [60] 
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 We have developed an integrated microfluidic biosensor that combines sample 
preconcentration with antibody-based detection and liposome-based signal 
amplification for sensitive detection of viruses. This device can be used in 
electrochemical detection mode by patterning gold interdigitated electrodes in the 
device and using electrochemical liposomes instead of fluorescent liposomes. The 
comparison of device performance for our integrated biosensor with various other 
detection systems is shown Table 1.1. When used in the electrochemical detection 
mode, our device has the advantages of low cost, portability and quantitative signal 
read-out.  
In Chapter 3, we describe the fabrication and characterization of the 
membrane-based preconcentration system and compare the advantages of this system 
with existing preconcentration techniques. We performed integrated concentration-
detection experiments using fluorescent liposomes for signal amplification and biotin-
streptavidin binding as the model system. We performed proof-of-principle 
experiments using this model system to show the improvement in performance of the 
device with the inclusion of electrokinetic preconcentration as opposed to a device that 
does not include any preconcentration.  
In Chapter 4, we show the detection of Feline Calicivirus (FCV) using the 
integrated microfluidic device. We chose FCV as a model organism for human enteric 
viruses [61]. We used capture and probe antibodies for the detection of FCV in a 
sandwich immunoassay and we used fluorescent liposomes for signal amplification. 
We performed microtiter plate assays to identify the optimal capture-probe antibody 
pair for best signals. Using these antibodies, we performed FCV detection experiments 
with our microfluidic device and estimated a limit of detection of 1.6 X 10
5
 PFU/ml. 
We then compared the performance of this device with a similar device that does not 
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include the preconcentration system and found that the integrated device shows a 
lower limit of detection. 
Finally, in Chapter 5, we summarized the accomplishments of these two 
projects and highlighted the path for future work.  
 
 
1.3 Taylor-Aris dispersion 
 
A common theme in both the protein refolding and virus detection devices is the effect 
of Taylor-Aris dispersion [62-65], which is a result of the combined effects of axial 
convection and radial diffusion of the molecules. In the microfluidic device for 
combinatorial protein refolding, the mixing of reagents in the rotary mixer is due to 
Taylor-Aris dispersion, which needs to be maximized for efficient mixing. The pump 
on the rotary mixer adds convection to the flow and helps to overcome the long 
mixing times characteristic of microfluidic flows which are low Reynolds number and 
high Peclet number flows. To get an estimate of the relative effects of convection and 
diffusion in this system, all the relevant geometric parameters of the channels and the 
diffusivity of dye molecules used in these mixing experiments are listed here. The 
diameter of the rotary mixer is 2.54 mm, which corresponds to a perimeter of 8 mm. 
The PDMS microchannels used in these experiments are about 10 µm deep and 100 
µm wide. The average velocity of the pressure-driven flow induced by the pump in the 
channels is 1 mm/s. The diffusivity of the dye molecules in the mixing experiment is 
on the order of 10
-10
 m
2
/s.  
 In the absence of convective flow induced by the pump, the only mixing 
mechanism for dye molecules in the rotary mixer is by axial diffusion. The timescale 
for this diffusion process scales as 2L D , where L is the perimeter of the rotary mixer 
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and D is the diffusivity of the dye molecules. For the values listed above, this 
timescale is on the order of 1000 min.  
 When axial convection is now added to this system, the dye molecules follow 
the parabolic flow profile of the pressure driven flow, with the fast-moving molecules 
in the center and the slow moving molecules close to the channel walls. The radial 
diffusion in this system causes the dye molecules to sample both the fast-moving and 
slow-moving parts of pressure-driven flow, reducing the dispersive effect of the 
convective flow. The two important parameters governing this flow are the Peclet 
number Pe ua D and the length ratio /L a . Here, u is the average velocity of 
pressure-driven flow and a  is the depth of the microchannels. For the rotary mixer, 
100Pe  and / 800L a  . For this regime where1 /Pe L a , the averaged 1-D 
equation for the convection-diffusion problem is given by 
 
 
2
2eff
c c c
u D
t x x
  
 
  
 (1.1) 
  
where the effective diffusivity effD for a large aspect ratio rectangular channel is given 
by [66] 
 
 
2
1 7.951
210
eff
Pe
D D
 
   
 
 (1.2) 
 
For 100Pe  , the value of effD is about 380D. The timescale for mixing with this 
increased effective diffusivity is now 2 / effL D which is 2.6 min (380 times lesser than 
the 1000 min case for pure diffusion). Thus, Taylor-Aris dispersion in the rotary mixer 
significantly reduces the mixing time of the reagents. 
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 On the other hand, in the microfluidic biosensor for virus detection, Taylor-
Aris dispersion needs to be eliminated for efficient concentration and elution. In 
Figure 1.1, the voltage settings during elution are shown on the microfluidic device.  
 
Electroosmotic
flow Induced pressure-
driven flow
150V 150V
0V 0V
0V 0V
 
 
Figure 1.1 (a): Direction of electroosmotic flow in the negatively charged glass 
microchannel in the integrated microfluidic biosensor when an electric field is applied 
during elution. (b): The membrane at the junction induces adverse pressure gradients 
in the channels to satisfy mass conservation, resulting in Poisueille flow.  
 
 
For the negatively charged glass channels, the direction of the electroosmotic flow 
upon applying an electric field is shown in Figure 1.1(a). The presence of the 
membrane at the junction of the microchannels leads to an adverse pressure gradient 
being induced in the channels as shown in Figure 1.1(b) to satisfy mass conservation. 
This pressure-driven flow causes dispersion of the concentrated bolus of analytes 
during elution. Additionally, external pressure gradients also cause dispersion of the 
concentrated bolus. This dispersion reduces the local concentration of the liposomes, 
countering the effect of the concentration system. The electroosmotic flow which is 
the source of this dispersive pressure-driven flow needs to be eliminated for efficient 
concentration and elution of analytes. Since the surface charge on the glass channels is 
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responsible for this electroosmotic flow, the channel walls are coated with linear 
polyacrylamide which is hydrophilic and uncharged [67]. This polyacrylamide coating 
reduces the zeta potential of the glass surface to almost zero, thereby eliminating the 
electroosmotic flow [67].  
Hence, in the protein refolding device, the effect of Taylor-Aris dispersion 
needs to be maximized for efficient mixing of the reagents, while in the virus detection 
device, this effect needs to be eliminated as it counters the effect of the 
preconcentration system. 
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CHAPTER 2 
REFOLDING OF β-GALACTOSIDASE: MICROFLUIDIC DEVICE FOR 
REAGENT METERING AND MIXING AND QUANTIFICATION OF 
REFOLDING YIELD 
 
 
2.1 Abstract 
 
We have developed a device that uses microfluidic valves and pumps to meter 
reagents for subsequent mixing with application to refolding of the protein β-
galactosidase. The microfluidic approach offers the potential advantages of 
automation, cost-effectiveness, compatibility with optical detection, and reduction in 
sample volumes as opposed to conventional techniques of hand-pipeting or using 
robotic systems.  The device is a multi-layered Poly(dimethylsiloxane) (PDMS) on 
glass device with automated controls for reagent aliquoting and mixing. Refolding 
experiments have been performed off-chip using existing protocols on the protein β-
galactosidase and the refolding yield has been quantified on-chip using fluorescein di-
β-D-galactopyranoside (FDG), a caged-fluorescent molecule. This work provides the 
potential to reduce the cost of drug discovery and realization of protein 
pharmaceuticals. 
 
 
2.2 Introduction 
 
Protein refolding has been a bottleneck in the production of biopharmaceuticals on a 
large scale. Synthesis of recombinant proteins in the biopharmaceutical industry uses 
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bacterial systems like E. coli as hosts. To over-express the production of recombinant 
proteins, promoters are used to induce genetically modified bacteria. This over-
expression leads to the formation of misfolded protein aggregates called inclusion 
bodies [1]The process of refolding involves the conversion of these non-functional 
protein aggregates to their functional native state. However, in most cases, the solution 
conditions to properly refold proteins are not known a priori. Determination of these 
solution conditions is a highly empirical process.  
The process of finding the reagents and buffers to properly refold proteins has 
been conventionally done by hand-pipeting, which is a highly time and labor-intensive 
process, or using robotic systems, which are very expensive. In either case, proteins 
are mixed combinatorially with various reagents on a 96-well plate, thus requiring 
expensive proteins and reagents on the order of several milliliters. The refolding yield 
is then quantified using various techniques like immuno affinity [2, 3] or spectroscopic 
methods [4].  
The microfluidic approach has many potential advantages compared to 
conventional techniques. The sample volumes used in microfluidic devices are on the 
order of nanoliters as opposed to milliliters used in the conventional methods, 
resulting in a million-fold volume reduction. Additionally, no expensive robotic 
control is involved for automation of fluid handling. Both these factors contribute to 
the cost-effectiveness of the microfluidic device.  
Kinetic measurements of protein conformation during unfolding and refolding 
are important in validating models for the folding process. Different methods are 
employed on microfluidic platforms to study the intermediate protein states like 
fluorescent dyes that bind to exposed hydrophobic regions of partially folded proteins 
[5] or techniques like small-angle x-ray scattering [6] and terahertz spectroscopy [7]. 
Our device is compatible with on-chip optical detection, which gives the potential for 
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real-time monitoring of these kinetic intermediates using the various techniques 
mentioned above.  
The upcoming sections are organized as follows: First, details of refolding of 
the protein β-galactosidase are discussed. Next, materials and methods to fabricate the 
device and implement the refolding protocol are discussed. The next section deals with 
device design to achieve refolding on-chip. The last few sections present the results, 
discussion and conclusion.  
  
 
2.3 β-Galactosidase refolding 
 
Refolding experiments are performed on the protein β-galactosidase, which is an 
essential enzyme in the human body that catalyzes the hydrolysis of β-galactosides 
like lactose into monosaccharides [8]. Commercial preparations of the enzyme are 
used in the preparation of lactose-free products and tablets to cater to the large lactose 
intolerant population. Apart from its biological activity, the enzyme has gained 
importance in molecular biology as a reporter protein [9, 10]. β-galactosidase is 
encoded by the lacZ gene of the lac operon in E.coli. Activity of a promoter that is 
fused to the lacZ gene can thus be detected by measuring the levels of β-galactosidase 
[9, 10]. 
The structural and enzymatic properties of the enzyme have been well 
characterized [10-16]. It is one of the largest tetrameric enzymes known at present, 
with a total of 1023 amino acids [17, 18]. Early studies on the protein showed that it 
can be denatured in the presence of high concentrations of urea [16, 19-21] while the 
folding pathway of the protein was studied by Nichtl et al. in 1998. 
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The denaturing protocol for the protein involves solubilizing in a buffer 
solution containing 8M urea [19].  The solubilized protein along with the denaturants 
is then diluted in a renaturing medium which mainly contains low concentration 
denaturing agent (1.4M urea) and  Mg
2+
 ions that aid refolding [19]. 
In this paper, we show the potential of our microfluidic device in automating 
fluid handling for performing protein refolding trials. On-chip refolding yield 
measurements are performed using a fluorometric assay on the protein β-
galactosidase. 
 
 
2.4 Materials and methods 
 
2.4.1 Reagents 
 
Urea, dithioerythritol (DTE), sodium phosphate, 1,1,2,2 tetrahydro – 
perfluorooctyltrichlorosilane, β-galactosidase from E. coli and dimethyl sulfoxide 
(DMSO) were from Sigma Aldrich (St. Louis, MO). Ethylene diamine tetraacetic acid 
(EDTA) and magnesium chloride were from EMD chemicals (Gibbstown, NJ). 
Fluorescein di-β-D-galactopyranoside (FDG) was from Invitrogen (Carlsbad, CA). 
 
2.4.2 Device fabrication 
 
The microfluidic device was fabricated using replica molding of 
poly(dimethylsiloxane) on microfabricated molds [22].  Device geometries were 
defined using L-Edit CAD software (Tanner Research). Two mask patterns were 
created using a GCA/Mann 3600F Optical Pattern Generator – one for the ‘flow 
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channels’, the channels through which the various reagents flow and the other for the 
‘control channels’, the channels through which pressurized air flows.  The silicon 
wafer used as a master for the flow channels was coated with a 9 µm thick layer of 
SPR 220-7.0 photoresist and the wafer used for the control channels was coated with a 
15 µm thick layer of SU-8 2010 photoresist. The wafers were then exposed using the 
corresponding masks using an EV 620 alignment tool. The SPR resist was developed 
using a 300MIF resist developer and the channels were rounded by reflowing at 120ºC 
for two minutes. The SU-8 resist was developed using SU-8 developer and rinsed with 
isopropyl alcohol and deionized water. Both the masters were surface treated by 
placing 30 µl of 1,1,2,2 tetrahydro – perfluorooctyltrichlorosilane in a vial along with 
the masters in vacuum for two hours [23]. 
 The PDMS layer containing the flow channels was about 5 mm thick and was 
prepared by mixing the two-part silicone elastomer (Dow Corning Sylgard® 184) in 
5:1 ratio and curing it over the flow master. The layer containing the control channels 
was about 17 µm thick and was prepared by mixing the elastomer in 20:1 ratio and 
spin coating the control master at 1750 rpm for 60s. The two PDMS layers were 
activated in the plasma cleaner and bonded together [23]. The two layered device was 
then bonded to a glass slide by a similar procedure. Tygon tubes were attached to the 
reservoirs of the control and flow channels. The control lines were connected to eight-
channel manifolds that were controlled through a BOB3 breakout controller board 
(Fluidigm, San Francisco, CA).  The opening/closing of valves and frequency of 
actuation of the pumps were controlled using an NI-DAQ card (NI 6533 - National 
Instruments) connected to the breakout board. The control interface was created using 
LabView program that allows for automation of the control process.   
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2.4.3 Device preparation 
 
In order to prevent the adhesion of proteins and other particles to the PDMS channels, 
the channel walls were coated with a layer of bovine serum albumin (BSA) which 
preferentially adheres to the channels. The channels were thoroughly purged with 
deionized water before performing multiple refolding trials. Implementing the 
refolding protocol on-chip requires long incubation times which may result in the 
evaporation of the reagents through PDMS. This can be prevented by placing the 
device in a water bath during long incubation hours. 
 
2.4.4 Denaturing and refolding protocols 
 
The denaturing and refolding protocols listed here were performed off-chip using 
standard pipeting techniques. β-Galactosidase was denatured by incubating 35 µg/ml 
of the protein in 8M urea, 1mM ethylene diamine tetraacetic acid (EDTA), 10 mM 
dithioerythritol (DTE), 0.1 M sodium phosphate (pH 7.5) at 25ºC for 2 hours. 
Refolding experiments were carried out by diluting the solubilized protein along with 
the denaturants 1:12 in a refolding medium containing 0.1M sodium phosphate, 1mM 
magnesium chloride, 5 mM DTE, 1.4M urea (pH 7.5). The protein was incubated in 
the refolding medium at 10ºC for 30 minutes and further incubated at 20 ºC for 12 
hours [19].  
 
2.4.5 Activity assay 
 
The activity of β-galactosidase was determined by a fluorometric assay using 
fluorescein di-β-D-galactopyranoside (FDG) as the substrate [24, 25]. Nonfluorescent 
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FDG was sequentially hydrolyzed by the enzyme, first to fluorescein 
monogalactosidase (FMG) and then to fluorescein, which is highly fluorescent. A 
20mM stock solution of FDG was prepared by dissolving 5 mg in 8:1:1 
H20/DMSO/ethanol solution. The assay was performed off-chip in a well plate by 
mixing equal volumes of refolded protein and FDG diluted to 0.2 mM solution, 
allowing 2 hours of incubation at room temperature. 
 
2.4.6 Fluorescence measurements 
 
The denatured and refolded protein samples were mixed with the diluted FDG solution 
off-chip and were allowed to incubate for 2 hours. The incubated mixtures were then 
introduced individually into the microchannels of the device. The emitted fluorescence 
was observed in the microchannel region using a Nikon TE2000U inverted 
fluorescence microscope with fixed excitation. Images were obtained using a Q-
Imaging Retiga camera and Phylum software. Image analysis was carried out in 
MATLAB.  
 
2.4.7 Image processing 
 
The volume injection rate of fluid in a flow channel was determined by monitoring the 
interface between water and dye and estimating the elapsed time for the dye-water 
interface to move a given distance using image processing tools in MATLAB. The 
mixing time of reagents in the annular mixer was estimated by visual inspection by 
filling about half the annulus with water and the other half with dye and actuating the 
peristaltic pump on the annulus.  
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2.5 Device design 
 
The microfluidic device was designed to enable automated fluidic handling of 
reagents.  This requires precise control over the choice and the amount of the various 
reagents which was achieved using a design consisting of two layers of 
poly(dimethylsiloxane) (PDMS) on glass [22]. PDMS is a popular elastomeric 
material that has been used for a number of microfluidic handling applications [26-
28]. A schematic of the channel layout is shown in Figure 2.1. The protein solution 
and the various reagents flow through the microchannels in the top thick PDMS layer. 
The channels in this layer called the ‘flow channels’ are 90 μm wide. Pressurized air 
was passed through the microchannels in the thin PDMS layer to control the flow of 
reagents in the flow layer. The channels in this thin layer, which is sandwiched 
between the top thick PDMS layer and the glass slide, are called ‘control channels’ 
and these channels are 120 μm wide. Each flow channel was equipped with a valve 
and pump to control the choice and amount of the reagents flowing through it. The 
chosen reagents were then mixed with the protein solution in the annular mixer [29] 
which has a radius of 1270 μm. The output was the protein refolded to different 
degrees depending on the solution conditions. The process was automated using a 
proprietary circuit and a LabView program. A picture of the device connected to a 
valve manifold is shown in Figure 2.2.  The degree of refolding was then quantified 
using a fluorometric assay [24, 25].  
The preliminary design of the device contains three input channels for 
conducting refolding trials. Subsequent versions can be expanded by incorporating 
multiple input channels for implementing complex combinatorial refolding protocols. 
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Figure 2.1 (a): Schematic of the channel layout with the red lines representing flow 
channels and the green lines representing control channels. (b): Peristaltic pump action 
in the device. (c): Valve action in the device. 
 
 
 
 
 
Figure 2.2: Microfluidic device integrated to an eight-valve manifold through tygon 
tubing. The size of the glass slide to which the PDMS layers are bonded is 2"x3". 
 
 
 
 
31 
2.6 Results 
 
Results described in this section are as follows: (1) The device was characterized by 
determining the optimum pumping frequency and mixing time of reagents in the 
annulus. (2) The refolding protocol and the fluorometric assay were optimized off-
chip for best on-chip signal intensity. (3) The fluorescence intensity was then 
calibrated as a function of β-galactosidase concentration in a PDMS microchannel. (4) 
Finally, the active protein content in denatured and refolded protein samples was 
quantified on-chip using the obtained calibration curve. 
 
2.6.1 Determination of optimum pumping frequency 
 
Fluid actuation was characterized to facilitate reagent metering. The flow rate of the 
fluid in the channel depends on the frequency of actuation of the peristaltic pump on 
the flow channel [22]. The peristaltic actuation of the control channels creates a 
positive displacement which results in fluid flow. The volume injection rate was 
calibrated against the frequency of actuation of the control channels as shown in 
Figure 2.3. The volume injection rate was determined using techniques described in 
section 2.4.7. The flow rate is maximum at a pumping frequency of about 10 Hz, 
beyond which the valve opening/closing is incomplete.  
 
2.6.2 Reagent mixing in the annulus 
 
The mixing time of reagents in the annulus was estimated by performing dye-water 
mixing experiments. The water and dye were introduced through the input channels 
into the mixing ring and the valves on all the channels connected to the ring were 
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closed. The pump on the ring was then actuated which resulted in the mixing of the 
water and dye solutions. Snapshots of the device during mixing are shown in Figure 
2.4. The mixing time was estimated as 45s using techniques described in section 2.4.7. 
The pump on the annulus is operated at 10 Hz actuation frequency. 
 
 
 
 
Figure 2.3: Volume injection rate in a flow channel plotted against the frequency of 
actuation of the control channels. 
 
 
 
 
 
 
Figure 2.4: Snapshots of the device at different times during mixing. Complete mixing 
is accomplished in about 45s. The flow rate of the fluid in the mixing ring upon 
actuation of the peristaltic pump is 1.07 nl/s. 
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2.6.3 Determination of optimum FDG incubation time 
 
As described in section 2.4.5, nonfluorescent FDG is used as the substrate for 
measuring β-galactosidase activity. β-Galactosidase sequentially hydrolyzes FDG first 
to FMG (fluorescein monogalactoside) which is not fluorescent and then to fluorescein 
which is highly fluorescent. The turnover rate for the hydrolysis of FDG to FMG is 
relatively slow (1.9 µmol min
-1
 mg
-1
) compared to the rate of conversion of FMG to 
fluorescein (22.7 µmol min
-1
 mg
-1
) [30]. This multistep hydrolysis results in a delay in 
the production of fluorescence. Hence for obtaining sensitive measurements, very 
short incubation times, typically less than 10 min, should be avoided. 
 
 
 
Figure 2.5: Fluorescence signal as a function of FDG – β Galactosidase incubation 
time. The line is a sigmoidal curve fit to the data. 
 
 
The fluorometric activity assay for quantifying the activity of β-galactosidase 
was performed with different FDG incubation times ranging from 0 through 270 
minutes. The incubation was performed off-chip at room temperature. Active β-
galactosidase at a very low concentration of 0.02 units/ml was used for these trials. A 
plot of the fluorescence signal intensity as a function of the incubation time is shown 
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in Figure 2.5. Increasing the reaction time results in an overall increase in signal. 
However, the curve describing the increasing trend in fluorescence begins to flatten at 
long incubation times (greater than 90 min.). All subsequent activity measurements 
were performed with an FDG incubation time of 120 min, based on the FDG - β-
galactosidase assay protocol in Huang 1991.   
 
 
 
Figure 2.6: Fluorescence signal intensity plotted as a function of dilution of the 
solubilized protein in the refolding buffer. 
 
 
2.6.4 Determination of optimum dilution ratio 
 
The refolding protocol was optimized off-chip by performing experiments with 
different dilutions of the solubilized protein in the renaturing buffer. The protein was 
denatured following the same protocol described in the materials and methods section. 
During refolding, the solubilized protein was diluted in different ratios in the 
renaturing buffer: 8, 10, 12, 18, and 36. FDG was added to these samples and 
incubated for 120 min. The fluorescence signal intensity was plotted as a function of 
dilution as shown in Figure 2.6. A dilution ratio of 12 results in the maximum 
fluorescence signal and this ratio was used in all subsequent refolding experiments. 
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2.6.5 Calibration of fluorescence intensity in a PDMS microchannel 
 
In order to quantify the refolding yield of β-galactosidase on-chip, the fluorescence 
intensity of the FDG – protein mixture was calibrated in the PDMS microchannel as a 
function of β-galactosidase concentration as shown in Figure 2.7. Active β-
galactosidase was used for these measurements with concentrations corresponding to 
2.5, 5, 10, 20, and 40 units/ml. The fluorescence intensity was calculated by 
processing fluorescent micrographs of the channel. The flattening of the curve 
observed at high protein concentrations is due to pixel saturation. 
 
 
 
Figure 2.7: Calibration curve of β-galactosidase concentration versus fluorescence 
intensity in a PDMS microchannel. The intensity is calculated by processing 
fluorescent micrographs of the channel. 
 
 
2.6.6 Quantifying active protein content in denatured and refolded samples on-
chip 
 
Multiple denaturing and refolding experiments were performed with β-galactosidase 
as per the optimized protocols described in the materials and methods section. The 
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refolding yield was determined using the fluorometric assay by quantifying the 
fluorescence intensity of denatured and refolded samples in the microchannel using 
image processing techniques. The micrographs of the device filled with denatured and 
refolded protein samples were used in conjunction with the calibration curve to 
estimate the refolding yield as 36.84%    20.96% as shown in the bar graph in Figure 
2.8. 
 
 
 
Figure 2.8: Micrograph of device filled with denatured and refolded β-galactosidase 
samples. The protein samples are incubated with FDG off-chip and introduced into the 
microchannels to quantify the yield. The bar graph shows the fluorescence intensities 
of the denatured and refolded samples (n=3). 
 
 
2.7 Discussion 
 
The refolding yields obtained in these trials are on the order of 36.84%    20.96%, 
comparable to the yields achieved in the existing literature which were on the order of 
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35 – 40% [19]. While these yields are still relatively low compared to the percentage 
refolding that has been achieved for other proteins such as lysozyme [31], these results 
demonstrate that on-chip reagent mixing characterization can be brought to bear on 
refolding problems.  
The main challenge in refolding proteins is the competing kinetics between 
aggregation and refolding [32]. The aggregated states correspond to local minima in 
the protein energy landscape [33]. These metastable states encountered in the folding 
pathways result in the formation of inclusion bodies. The most common technique to 
overcome aggregation is to use very dilute solutions of protein during refolding. 
However, dilute solutions are not cost-effective.  Hence recent refolding trials have 
resorted to the use of small concentrations of denaturants and other reagents that aid 
refolding by minimizing aggregation. These synthetic reagents which comprise 
different types of surfactants, salts and sugars that aid in refolding are called artificial 
chaperones [31]. By combinatorially choosing these artificial chaperones using our 
microfluidic device, the refolding yield can be improved. 
Another technique to improve the refolding yield is to add molecular 
chaperones like GroEL to the renaturing buffer, that aid in folding by encapsulating 
individual proteins, thereby preventing aggregation [34]. It has been shown that  the 
presence of GroEL results in a two-fold increase of the in-vitro refolding yield of β-
galactosidase [34]. 
 As mentioned earlier, our microfluidic approach provides a cost-effective way 
to implement refolding protocols because the volumes of reagents used in the trials are 
on the order of nanoliters and automation does not require the use of expensive robotic 
systems. Since the device is optically clear, it is compatible with on-chip detection of 
protein intermediates. The process of scaling up to implement complex combinatorial 
protocols involves the fabrication of multiple refolding mixers on a single chip to 
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parallelize the reactions. It has been shown that microfluidic large-scale integration 
using multiplexors allows control over a large network of fluidic channels with 
minimal number of inputs [27]. 
 
 
2.8  Conclusion 
 
We have shown the potential of our microfluidic approach in automating fluid 
handling and have evaluated protein refolding protocols with on-chip measurements. 
We have demonstrated the capability of our device in controlling reagent metering and 
mixing by performing experiments with dye-water solutions and mixing them in an 
annular mixer in an automated fashion. We have optimized a refolding protocol and 
fluorometric assay off-chip for best on-chip signal intensity, and shown that denatured 
and refolded samples of the protein β-galactosidase can be quantified on-chip using a 
fluorescence based assay. 
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CHAPTER 3 
INTEGRATED MICROFLUIDIC PRECONCENTRATOR  
AND IMMUNOBIOSENSOR  
 
3.1  Abstract 
 
We present a microfluidic biosensor that integrates membrane-based preconcentration 
with fluorescence detection. The concentration membrane was fabricated in 
polyacrylamide by in-situ photopolymerization technique at the junction of glass 
microchannels. Liposomes entrapping sulforhodamine B (SRB) dye molecules were 
used for signal amplification. The biotin-streptavidin binding system was a model 
system for evaluating device performance. Biotinylated liposomes were 
preconcentrated at the membrane by applying an electric field across the membrane. 
The electric field causes the liposomes to migrate towards the membrane where they 
are concentrated by a sieving effect. Two orders of magnitude concentration was 
achieved after applying the electric field for only 2 min. The concentrated bolus was 
then eluted towards the detection unit, where the biotinylated liposomes were captured 
by immobilized streptavidin. The integrated system with the preconcentration module 
shows a fourteen-fold improvement in signal as opposed to a system that does not 
include preconcentration. 
 
3.2 Introduction 
 
Microfluidic systems have become increasingly popular in biological and chemical 
analyses owing to the advantages of minimal reagent use, cost-effectiveness and 
automation [1-4]. An important application of microfluidic systems has been in the 
44 
field of biosensors for pathogen detection and clinical diagnostics [5-7]. However, the 
use of microfluidic devices for the total analysis of a whole sample has been limited 
due to the challenges associated with integration of the different processing steps like 
sample preparation, preconcentration, analysis and detection on the same device [8-
12]. In this paper, we present an integrated microfluidic immunobiosensor that 
combines preconcentration and fluorescence detection steps to enable sensitive 
detection in dilute samples.  
Preconcentration of sample prior to analysis is an important step in 
microfluidic systems as it enables detection of very small concentrations of analytes 
and also improves detection sensitivity and signal-to-noise ratios. A number of 
preconcentration techniques have been developed that can achieve high concentration 
factors in small time durations. Some examples include surface-binding techniques 
like solid-phase extraction [13-16] and electrokinetic manipulation techniques like 
isoelectric focusing [17-19], field-amplified sample stacking [20, 21], isotachophoresis 
[22-25] and dielectrophoresis [26, 27]. However, the limitations of these techniques 
are that they either involve buffer handling challenges or fabrication complexities 
making them difficult to integrate with lab-on-chip systems. Porous membrane-based 
preconcentration systems, on the other hand, do not involve complex buffer systems to 
concentrate samples. Khandurina et al. [28, 29] demonstrated the use of a porous 
silicate membrane while Wang et al. [30] used a nanofluidic filter for 
preconcentration. However, in the former case, the authors reported that the silicate 
membranes were hard to fabricate in a reproducible manner and the latter approach 
involves the fabrication of micro- and nanochannels in the same device. More 
recently, Kim et al. [31] have developed self-sealed nanoporous junctions inside 
PDMS microchannels for preconcentration. However, PDMS-based devices are less 
robust and are prone to surface adhesion and reusability issues. 
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We use an in-situ photopolymerized nanoporous membrane [32-34] in our 
integrated glass microfluidic device for the preconcentration step. Song et al. [32] 
have shown high concentration factors (four orders of magnitude local concentration) 
using these nanoporous membranes. The in-situ fabrication technique allows for easy 
integration with total analysis systems. Our membranes are fabricated in 
polyacrylamide as it is hydrophilic, biocompatible and shows minimal non-specific 
adhesion [34]. The pore-size of acrylamide gels can be easily adjusted by changing the 
percentage of monomer components [35, 36]. Moreover, unlike other membrane-
based concentration methods, the response of this system is linear with the voltage-
time product [32]. 
Figure 3.1 shows the integrated microfluidic biosensor with the insets showing 
the concentration membrane and the detection region. The membrane is nanoporous 
and is made using polyacrylamide at the intersection of the glass channels by an in-
situ photopolymerization technique [32-34, 37-39]. We use liposomes, which can 
encapsulate a very large number of fluorescent dye molecules in their core for signal 
amplification in the biosensor. Fluorescence from the dye molecules is quenched when 
they are encapsulated at a high concentration within the liposome core. The analytes to 
be detected are tagged with liposomes and these complexes are injected into the inlet 
well of the device. An electric field is applied across the membrane, causing the 
liposome-analyte complexes to migrate towards the membrane. However, since the 
size of the pores in the membranes is much smaller than the size of these complexes, 
they are concentrated at the membrane by a sieving effect. The concentrated bolus is 
then eluted towards the detection region, where these complexes are captured using 
immobilized antibodies. The captured liposomes are then lysed by flowing a detergent 
and the released fluorophores result in a significant signal enhancement due to the 
elimination of self-quenching of the dye molecules. 
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In this paper, we present results showing improved detection sensitivity with 
the inclusion of the preconcentration system using proof-of-concept experiments 
performed with biotin-streptavidin binding. 
 
Polyacrylamide membrane
for sample concentration
Antibody capture
Liposome Analyte Antibody
Analyte-liposome  complexes 
injected into device
1 cm
 
 
Figure 3.1: Image of the integrated glass microfluidic device with the channels filled 
with food dye to show contrast.  The insets show a picture of the polyacrylamide 
membrane-based concentrator and schematics of antigen-antibody binding in the 
device. 
 
 
3.3 Experimental methods 
 
3.3.1 Fabrication of microfluidic channels 
 
Schott D263 glass wafers (100 mm diameter, 0.55 mm thick; S I Howard Co., 
Worcester, MA) were used for etching microfluidic channels. Device geometry was 
defined using L-Edit CAD software (Tanner Research) and a photomask was created 
using GCA/Mann 3600F Optical Pattern Generator. A 225nm thick layer of 
amorphous silicon deposited on the glass wafers by PECVD was used as the hard 
mask for etching. The wafers were then coated with a 3µm thick layer of Shipley 1818 
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positive photoresist and soft-baked at 115ºC for 1 min. The mask pattern was 
transferred to the photoresist using an EV 620 contact aligner and the wafers were 
developed using a 300MIF resist developer. The exposed silicon was etched using an 
Oxford 80 (#1) reactive ion etching (RIE) system and the photoresist was stripped 
using a mixture of acetone and isopropanol. The exposed glass was etched using a 
16% HF solution (Shape Products Company, Oakland, CA). The glass wafers were 
exposed to HF for 14 min, resulting in channel depths of 20 µm (etch rate of D263 
glass in 16% HF is about 1.4 µm/min when left unagitated). Finally, the remaining 
silicon on the wafers was removed by reactive ion etching using the Oxford 80 (#1) 
system. In the final device, the wide channel width was 120 µm and the narrow 
channel width was 50 µm. The depths of the channels in both cases were 20 µm. 
Connection holes were made in the wafers by sandblasting. 
  
3.3.2 Wafer bonding 
 
The glass microchannels were sealed by a plain borofloat glass wafer (100 mm 
diameter, 500 µm thick; Mark Optics, Santa Ana, CA) using a low temperature glass 
bonding technique [28, 29, 40, 41]. The etched and the plain glass wafers were 
cleaned by sonicating in acetone for about 5 min. The wafers were then hydrolyzed in 
RCA cleaning solution (prepared by mixing 5N ammonium hydroxide, 30% w/w 
hydrogen peroxide and deionized water in 3:2:9 ratio by volume) for 20 min at 70-80 
ºC, rinsed in deionized water and dried under nitrogen. This was followed by plasma 
cleaning to activate the surfaces of both the wafers prior to bonding. A thin layer of 
potassium silicate (KASIL 2130, The PQ Corp., Valley Forge, PA) was coated on the 
plain glass wafer by spinning a diluted solution (1:10 by weight in deionized water) at 
2000 rpm for 8s. As the spin-coated wafer was then brought into contact with the 
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etched glass wafer, the bonding region spread instantaneously across the entire area of 
the wafers. The bonded wafers were then placed in a hot press at 90 ºC for an hour to 
reinforce the bonding.  
  
3.3.3 Membrane fabrication and surface treatment 
 
The channels of the bonded devices were treated with 1M NaOH for 20 min to remove 
the potassium silicate layer in the microchannels. The wafers were then rinsed with DI 
water and dried in nitrogen. Prior to membrane fabrication, the glass channels were 
coated with an acrylate-terminated self-assembling monolayer to enable covalent 
attachment of the polyacrylamide membrane to the channel walls[42-44]. For this, the 
channels were prepared by exposing to 1M HCl for 30min, rinsing in DI water and 
then exposing to 1M NaOH for 30 min. The channels were thoroughly rinsed with DI 
water and then exposed to a freshly mixed coating solution containing 2:3:5 mixture 
(by volume) of 3-(trimethoxysilyl)propyl acrylate, glacial acetic acid and deionized 
water for exactly 30 min. The channels were finally rinsed in 1-propanol and DI water 
and dried with vacuum. 
The polyacrylamide membrane was fabricated at the intersection of the glass 
microchannels by a photopolymerization technique [32-34, 37-39]. For this, a 355 nm 
laser beam was shaped using a train of lenses and mirrors into a long narrow beam to 
match the dimensions of the channel junction. The optical train also helps to direct the 
beam through a microscope to enable visualization of the polymerization process. The 
channels were filled with a freshly prepared and degassed solution of 22% (15.7:1) 
acrylamide/bisacrylamide containing 0.2% (w/v) VA-086 photoinitiator [34]. All the 
reservoirs were capped with tape to prevent evaporation, and the solution was allowed 
to equilibrate for 20 min to eliminate pressure-driven flow. The membrane was then 
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fabricated by directing the shaped laser beam towards the junction and exposing for 
approximately 15s. The unpolymerized acrylamide solution was purged from the 
channels and the channels were rinsed thoroughly with DI water.  
Finally, the channels were coated with linear polyacrylamide to suppress the 
electroosmotic flow [42-44]. The channels were filled with a degassed solution of 50 
mg/ml acrylamide in deionized water containing 250 ppm hydroquinone and 2 mg/ml 
V-50 photoinitiator and exposed to UV light in a UV oven for 30 min. The 
unpolymerized solution was rinsed out of the channels and the channels were cleaned 
with DI water.  
 
3.3.4 Liposome and magnetic bead preparation  
 
Liposomes were prepared by a modified version [45] of the reversed-phase 
evaporation technique described by Siebert et al [46].  All lipids used were obtained 
from Avanti Polar Lipids (Alabaster, AL). Fluorescent liposomes encapsulate 150mM 
sulforhodamine B (SRB) dye in 0.02M HEPES, pH 7.5 in the core and also contain 
0.33mol% dipalmitoyl phosphoethanolamine (DPPE)-rhodamine in the bilayer. 
Biotinylated lipids were used in the preparation of the liposomes in order to add 
functionality to the outer surface of the bilayer. The remainder of the bilayer consists 
of 35mol% dipalmitoyl phosphatidylcholine (DPPC), 15mol% dipalmitoyl 
phosphatidylglycerol (DPPG), 42mol% cholesterol, and 6mol% N-(glutaryl)-1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine. After formation of the vesicles, 
extrusions through 1µm and 0.4 µm filters was performed to assure unilamellar 
liposomes with a uniform size distribution. Removal of unencapsulated SRB was 
facilitated by application of the liposome preparation to a Sephadex G-50 column 
equilibrated with 0.01 M HEPES, pH 7.5, containing 0.2 M NaCl, 0.2 M sucrose, and 
50 
0.01% sodium azide (NaN3). Fractions containing liposomes were collected and 
dialyzed against 0.01 M HEPES, 0.2 M NaCl, 0.2 M sucrose, 0.01% NaN3 pH 7.5 
(1XHSS) in the dark overnight. 
To capture these biotinylated liposomes in the microfluidic device, 
commercially available streptavidin-conjugated superparamagnetic beads (Dynabeads 
MyOne Streptavidin, 1 μm in diameter; Invitrogen, Carlsbad, CA) were used. Prior to 
use, the stock was vortexed to homogenize the suspension and the necessary volume 
was removed. In order to remove preservatives and introduce the working buffer, the 
beads were then washed twice with an equal volume of 1XHSSby applying the tube to 
a magnet rack, removing the supernatant, and resuspending. 
 
3.3.5 Sample loading, concentration and detection  
 
Prior to performing concentration and detection experiments, the channels of the 
device were primed with 1X HSS buffer. A permanent magnet was positioned on the 
top surface of the device upstream of the detection region using adhesive putty. 1 µl of 
Dynabeads MyOne streptavidin-conjugated superparamagnetic beads prepared in 1X 
HSS buffer was injected towards the magnet through the port 5 (Figure 3.2) using a 
syringe pump at a flow rate of 1 µl/min. For the electrokinetic concentration 
experiments, a solution of 10,000x diluted fluorescent liposomes (biotinylated with 
SRB dye in the core) in HSS buffer was used. For the direct injection experiments, the 
liposome solution was further diluted by a factor of 10 in HSS buffer (due to lowest 
achievable flow rate limitations with our existing equipment) so that the same number 
of liposomes is flowed through the device for performance comparison.  
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Figure 3.2: Schematic of device used for the biotin-streptavidin experiments in 
fluorescence detection mode. Biotinylated liposomes are captured by streptavidin-
conjugated magnetic beads localized at the magnet. The fluorescence from the lysed 
liposomes is imaged downstream from the magnet in the region marked as the 
fluorescence measurement window. 
 
 
For the direct injection experiments, the biotinylated liposome solution in HSS 
buffer was injected towards the magnet with a syringe pump at a flow rate of 10 µl/h 
for 90s through inlet port 1 (Figure 3.2). After liposome injection, wash buffer was 
injected at a flow rate of 20 µl/h to wash off any unbound liposomes in the device 
through port 5. A detergent solution of 60mM octyl-β-D-glucopyranoside (OG) was 
then flowed through the same port 5 towards the bead bed at a flow rate of 40 µl/h and 
the emitted fluorescence from the lysis of the liposomes was recorded downstream of 
the bead bed. 
For the electrokinetic concentration experiment, all the wells were filled with 
60 µl of plain HSS buffer except the inlet well which was filled with the liposome-
HSS solution. The pressure driven flow in the system was eliminated by adjusting the 
heights of the solutions in the wells. The liposomes were then electrophoretically 
concentrated at the membrane by applying a voltage difference of 150V across the 
membrane. After concentrating for a duration of 90s, the concentrated bolus of 
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liposomes was eluted towards the bead bed by applying a voltage of 150V to the outlet 
port 3 downstream of the magnet. The wash buffer and OG solutions were injected at 
the same flow rates as in the above case through port 5 and the fluorescence signal 
from the lysed liposomes was recorded downstream of the magnet. 
For each experiment, the background was calculated as the average of the total 
fluorescence intensity values estimated in the region of interest during the first 60 
frames of the detergent injection videos. 
After each run, the device was thoroughly rinsed with deionized water multiple 
times followed by a final rinse which involves flowing deionized water at a rate of 2 
µl/min with a syringe pump for 15 min.  
 
 
3.4 Results  
 
3.4.1 Electrophoretic concentration of fluorescent liposomes 
 
Concentration and elution experiments were performed using fluorescent liposomes to 
estimate the concentration factors for the membrane-based preconcentration system. 
Figure 3.3 shows snapshots of the channel junction during the concentration and 
elution steps achieved by switching electric fields between the vertical and horizontal 
channels. Figure 3.4 shows the concentration factor plotted as a function of time for 
which the high voltage is applied across ports 1 and 4 (Figure 3.3(a)). It can be seen 
from Figure 3.4 that after a concentration time of 160s, the estimated concentration  
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Figure 3.3: Image sequence showing liposome concentration and elution. 
Microchannel edges have been drawn for clarity. The membrane has also been 
highlighted in blue in Figure 3.3(a). HV denotes high voltage (100V), PV pinch 
voltage (40V), Gnd ground. (a) Before loading (b) Sample concentration (c) After 
concentration (d) Sample elution. Pinch voltage is applied to minimize the diffusion of 
the sample away from the membrane.  
 
 
 
 
 
Figure 3.4: Concentration factors during liposome concentration as a function of time. 
The intensities were averaged over a measurement window (23 x 180 pixels) shown as 
a box in the inset. The concentration factors are consistent with analytical values 
estimated using a liposome zeta potential of -19mV.  
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factor was around 230. Analytical calculations resulted in concentration factors of 
around 350 for 160s of applying high voltage which is on the same order of magnitude 
as the experimental value. For these calculations, the zeta potential of the liposomes 
estimated from Zetasizer measurements was -28.8 ±2.9 mV (resulting in a mean 
electrophoretic velocity of 103.1 µm/s), while the inferred zeta potential from the 
experiments was -19 mV. The trend in Figure 3.4 is linear as expected as the 
liposomes migrate with a constant electrophoretic velocity. 
 
3.4.2 Integrated concentration and detection experiments 
 
Concentration and detection experiments were performed with the biotin-streptavidin 
binding system in the integrated microfluidic device. For these experiments, 
biotinylated fluorescent liposomes (with SRB dye in the core and bilayer) were used 
as the analytes to be detected. Streptavidin coated magnetic beads immobilized in the 
channels using a permanent magnet served as the capture region. The liposomes were 
electrophoretically concentrated at the membrane by applying a high voltage across 
the membrane. The concentrated bolus of liposomes was eluted by switching the 
electric field towards the bead bed where the liposomes are captured. Figure 3.5 shows 
an image of the bead bed with the captured fluorescent liposomes. The unbound 
liposomes were washed away by flowing 1X HSS as wash buffer over the bead bed. 
The OG solution was then injected into the channels, resulting in the lysis of the 
bound liposomes. The released fluorescence from the liposomes was captured 
downstream in the region indicated as the fluorescence measurement window in 
Figure 3.2. Snapshots from the fluorescence burst during OG injection in the region of 
interest are shown in Figure 3.6.  
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Figure 3.5: Fluorescent liposomes captured at the bead bed immobilized using a 
permanent magnet. 
 
 
 
 
 
Figure 3.6: Snapshots of the fluorescence measurement window (shown as a red box) 
during OG injection. (a): Background image before the start of injection. (b), (c), (d): 
Snapshots during fluorescence burst from the lysed liposomes during OG injection. 
 
 
3.4.3 Comparison of device performance with and without concentration 
 
In order to evaluate the effect of the preconcentration step on the performance of the 
system, direct injection experiments were performed where the liposomes were 
injected towards the bead bed using a syringe pump bypassing the concentration step. 
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The number of liposomes in the device was maintained the same for both sets of 
experiments – with and without the preconcentration step.  
The total fluorescence intensity in the measurement window during OG 
injection was estimated from the captured videos of fluorescence burst and plotted as a 
function of time. These intensity profiles are shown in Figure 3.7. This figure shows 
data from both the electrokinetic concentration (shown in red) and direct injection 
(shown in blue) experiments. The area under these curves gives the integrated 
fluorescence intensities for each of these experiments. These integrated intensities for 
the electrokinetic concentration and direct injection cases are compared in Figure 3.8. 
This figure shows that the inclusion of the preconcentration step increases the signal 
by a factor of 14. The increased signal is a result of a concentrated bolus of liposomes 
flowing over the bead bed resulting in better capture efficiencies than in the case 
where a dilute solution of the same number of liposomes is flowed.  
 
 
3.5 Discussion 
 
The detection sensitivity of the biosensor depends on the binding kinetics between the 
low concentration of an analyte and the surface immobilized biorecognition element. 
This process is usually diffusion-limited [47-49], and an increase in the local analyte 
concentration in the capture region greatly improves the binding kinetics. Singh and 
coworkers [10, 34] have used similar membrane-based preconcentrators in 
conjunction with microchip SDS-PAGE and electrophoretic immunoassays to show 
improved separation resolution and detection limits. Wang et al. [50] have shown 500-
fold improvement in sensitivity (from 50 pM to sub 100fM) and improved dynamic 
range of immunoassay detection using nanofluidic filter based electrokinetic  
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Figure 3.7: Fluorescence intensity profiles from the bead bed during OG injection for 
the two experiments including the preconcentration step (shown in red lines) and 
excluding it (shown in blue lines). 
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Figure 3.8: Comparison of the effect of preconcentration on the integrated 
fluorescence intensities from the bead bed during OG injection. The data is reported as 
mean ± SD with n=3. * indicates p<0.05. 
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preconcentrator. However, this device has fabrication complexities as it involves 
etching of both micro- and nanochannels in the same device. Also, the improvement in 
sensitivity has been reported for molecular analytes like proteins and does not include 
any post-binding amplification steps.  
Our design and fabrication techniques are compatible for integrating 
electrochemical detection into the device. The device can be operated in 
electrochemical detection mode by patterning gold interdigitated electrodes 
downstream from the membrane and using electrochemical liposomes instead of 
fluorescent ones [51]. The low temperature bonding technique is suitable for bonding 
etched glass wafers with gold-patterned wafers as it does not lead to delamination of 
the gold electrodes as seen in the conventional high temperature bonding techniques. 
Also, the core of the liposomes can be filled with electrochemical species such as 
potassium ferri/ferro hexacyanide molecules instead of fluorophores for detection. 
This straightforward extension to an electrochemical system is advantageous as 
electrochemical detection methods offer several benefits over popularly used optical 
detection techniques. These include low capital cost for equipment, portability, low 
power requirement and lack of photobleaching issues [52, 53].  
 
 
3.6 Conclusion 
 
In conclusion, we have presented an integrated microfluidic biosensor that integrates 
on-chip concentration with liposome-based signal amplification on the same device. 
We have achieved two orders of magnitude concentration with the membrane-based 
system within 160s of applying high voltage across the membrane. The electric field 
can be switched to elute the concentrated sample bolus towards the detection region 
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where it is captured efficiently at the immobilized bead bed. The inclusion of the 
preconcentration step results in a fourteen-fold improvement in the signal as opposed 
to a system without the preconcentration step, when the same number of liposomes is 
introduced in both cases. The functionality of the membrane can be extended to a 
filtering device for removing small interfering particles that competitively bind to the 
target probes, further increasing the signal-to-noise ratio.  
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CHAPTER 4 
MICRO-TOTAL ANALYSIS SYSTEM FOR VIRUS DETECTION – 
MICROFLUIDIC PRECONCENTRATION COUPLED TO  
LIPOSOME-BASED DETECTION 
 
 
4.1 Abstract 
 
In this work, an integrated microfluidic biosensor is presented, that combines sample 
preconcentration and liposome-based signal amplification for the detection of enteric 
viruses in environmental water samples. This microfluidic approach has the potential 
to overcome the challenges of long culture times for cell-culture methods and the need 
to extensively process water samples to eliminate inhibitors for PCR-based methods. 
In-situ fabricated nanoporous membranes in glass microchannels were used in 
conjunction with electric fields to achieve preconcentration of virus-liposome 
complexes. The concentrated complexes were eluted to a detection region downstream 
and the captured liposomes were lysed to release fluorescent dye molecules that were 
quantified using image processing. Detection experiments were performed on Feline 
Calicivirus (FCV), which was chosen as the model organism for human enteric virus. 
The limit of detection of FCV estimated with the integrated device was an order of 
magnitude lower than that obtained using a device which does not include 
preconcentration. This improved detection sensitivity indicates that the integrated 
device has the potential to serve as an early screening system for viruses in 
environmental water samples.  
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4.2 Introduction 
 
Enteric viruses are any one of over 100 species that infect humans or animals via the 
fecal-oral route and primarily infect and replicate in the gastrointestinal tract. Though 
these viruses are commonly associated with gastroenteritis they can cause a range of 
diseases including respiratory infections, hepatitis, conjunctivitis and meningitis [1]. 
They have even been linked to chronic diseases like insulin-dependent diabetes [2].  
Once infected, humans or host animals shed virus particles in feces. Enteric 
viruses are then introduced into water systems mostly through leaking sewage and 
septic systems, urban and agricultural runoff, and directly from untreated or under-
treated wastewater. Outbreaks have been linked to not only contaminated drinking 
water, but also to contaminated recreational and irrigation water as well as shellfish 
harvested from contaminated waters [3]. These pathogenic viruses are highly resistant 
to changes in pH and temperature as well as to common methods of wastewater 
treatment. It has been shown that these viruses can remain infective up to 130 days in 
seawater, 120 days in freshwater and sewage, and 100 days in soil [1]. Depending on 
the source of contamination and water supply in question, virus particles can present 
in low concentrations complicating both detection and sterilization methods. 
Current detection methods for enteric viruses can be divided into two main 
categories, cell culture assays and molecular methods. The cell culture technique was 
the most popular method for detection of enteric viruses prior to the development of 
the Polymerase Chain Reaction (PCR) and remains the method of choice to isolate and 
determine infectivity of viruses. The cell culture technique requires the inoculation of 
a cell line, chosen based on the virus of interest, and incubating for days to weeks as it 
is evaluated for the cytopathogenic effects of a viral infection [4]. This long incubation 
time is an obvious drawback of the cell culture assay though is not the only; some 
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viruses do not grow on established culture lines, grow too slowly, or just do not show 
any visible cytopathogenic effects.  
The molecular methods most commonly used for the detection of enteric 
viruses are variations of conventional PCR [5] or reverse transcriptase-PCR (RT-PCR) 
[6], including real-time PCR [7] and multiplex PCR [8], as well as Nucleic Acid 
Sequence-Based Amplification (NASBA) [9]. These methods allow for the rapid, 
sensitive, and specific detection of enteric viruses of interest. The primary drawback to 
these molecular methods is the inability to limit detection to only infective viruses. 
However, this can be remedied by the use of integrated cell culture RT-PCR. This 
method involves inoculating a cell line with the sample and incubating for a short 
time, usually far before cytopathogenic effects are evident. Nucleic acids can then be 
extracted from the culture and processed through RT-PCR, testing for viral mRNA 
that would be produced only if the sample contained infective viruses. This process 
can, however, decrease the efficiency of detection [10].  
As some enteric viruses are not cultivable and molecular techniques sacrifice 
efficiency of detection for an ability to identify infective viruses, many countries, 
including the United States, rely on indicators of fecal contamination - enterococci, 
coliform bacteria - rather than direct testing. Reliance on these indicators is flawed as 
viruses are more resistant to disinfection processes and natural environmental 
conditions [11, 12]. 
Feline Calicivirus (FCV) is a member of the caliciviridae family that causes 
respiratory and potentially severe systemic disease in cats. As it is non-pathogenic to 
humans and a member of the same family, FCV is used as a model for human 
pathogenic noroviruses [13]. Enzyme-Linked Immunosorbent Assays (ELISAs) for 
the detection of FCV have been previously described using two antibodies [14] and an 
antibody and a transmembrane glycoprotein [15]. Detection limits were not reported 
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as the developed ELISAs were used to screen antibodies [14] or determine the binding 
domain of the glycoprotein [15]. However, methods have been reported employing 
Atomic Force Microscopy (AFM) and Surface-Enhanced Raman Spectroscopy 
(SERS) for detection of FCV with a limits of detection of 3 million and 1million 
virions/ml, respectively [16]. 
Biosensors are an attractive detection method for molecules and small 
particles, such as virions, as they can produce rapid, sensitive and specific signals [17-
22]. Both microfluidic and lateral flow assays using liposome nanovesicles as a visual 
or electrochemical signal generation and amplification system have been well-
established using nucleic acids [17-22] and antibodies [23-25] as capture molecules, 
depending on the target being detected. Additionally, novel biological recognition 
elements have been employed in similar assays, such as using ganglioside-
incorporating liposomes for the detection of cholera toxin subunit B [26].  
The often low concentration of virions in water samples, can be a challenge 
[11]. Addressing this, herein described is the use of a microfluidic device combining 
pre-concentration and fluorescent detection, previously described [27], to detect FCV. 
Pre-concentration of the virus particles can be achieved by first allowing liposomes 
tagged with specific anti-FCV antibodies to bind and then actuating the complexes 
toward a nanoporous membrane via electrokinetics [27, 28]. These complexes can 
then be eluted from the membrane as a bolus and applied to a downstream capture and 
detection zone. 
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4.3 Materials and methods 
 
4.3.1 Biotinylation of antibodies 
 
Biotin was conjugated to antibodies using the EZ-Link® NHS-PEG4-Biotin kit and 
purified using the Slide-A-Lyzer® mini-dialysis kit (Pierce Rockford, IL). Briefly, 
100µl of 1mg/ml antibodies were added to the Slide-A-Lyzer tubes and dialyzed 
against 1XPBS, pH 7.0 to exchange the buffer and assure appropriate pH. Biotin was 
then added at more than a 20-molar excess to assure good conjugation at the relatively 
low antibody concentration and the samples were incubated for 30 min at room 
temperature. The samples were again dialyzed against 1XPBS, pH 7.0 in order to 
remove the excess biotin. Samples were collected out of the dialysis tubes and stored 
in the refrigerator.  
 
4.3.2 Preparation of capture beads 
 
Polyclonal anti-FCV antibodies (Baker Institute, Ithaca, NY) were purified from rabbit 
serum with a HiTrap Protein A HP column (GE Healthcare Uppsala, SE) as per 
manufacturer suggestions. Once purified, polyclonal antibodies were then conjugated 
to Protein-A magnetic beads from Dynabeads Immunoprecipitation kit (Invitrogen, 
Carlsbad, CA) as per manufacturer provided instructions.  
 
4.3.3 Preparation of streptavidin-conjugated liposomes 
 
Fluorescent streptavidin-conjugated liposomes were prepared via the reverse-phase 
evaporation method using 150mM sulforhodamine B (SRB), 20mM HEPES, pH 7.5 
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as the encapsulant as previously described [29] with modification. To allow for 
visualization of the liposomes during the concentration procedure a fluorphore-labeled 
lipid (Avanti Polar Lipids Alabaster, AL), 0.33mol% 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl), was added to the initial 
lipid mixture. Liposomes coupled to streptavidin were incubated for 15 minutes at 
room temperature, with 1µg anti-FCV monoclonal antibody (Abcam Cambridge, 
MA), biotinylated as above. Liposome-antibody conjugate was then diluted to a 
working phospholipid concentration of 0.7mM. 
Liposomes with the same bilayer composition and streptavidin-modification 
were also prepared with an encapsulant of potassium ferri/ferrohexacyanide with a 
combined concentration of 200mM for experiments using amperometric detection. 
These liposomes were prepared in 1X HEPES-Saline-Sucrose (1XHSS), containing 
10mM HEPES, 200mM NaCl, and 200mM sucrose, pH 7.5 but then dialyzed against 
1XPBS, 20mM sucrose, pH7.5, as HEPES has been shown to interfere with 
electrochemistry [30, 31]. 
 
4.3.4 Microtiter plate liposome immunoassay (LIA) for antibody selection 
 
Previously reported protocols for the use of liposomes in microtiter [32] were adapted 
and modified for virus detection. High-binding Nunc Maxisorb® polystyrene plates 
were prepared for a Liposome Immunoassay (LIA) by washing each well with 200μl 
of 1X PBS. Anti-FCV antibodies were diluted with 1X PBS to 5μg/ml and 200μl were 
added to each well. The plates were then incubated overnight in the refrigerator. After 
incubation, wells were emptied, tapped dry, and washed with 200μl of 1X PBS. Wells 
were blocked for 1 hour at room temperature with 200μl of blocking reagents 
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containing either 0.05% Tween-20 or 0.1% Tween-20 in 1X PBS. Plates were then 
emptied, dried and washed twice with 200μl per well of 1X PBS. 
Prepared plates were then loaded with 100μl per well of varying concentrations 
of FCV in 1X PBS in triplicate and incubated for 2 hours in the refrigerator with 
gently shaking. Wells were tapped dry and washed twice with 200μl of 1X PBS. 
Biotinylated anti-FCV antibodies were diluted in 1X PBS to a concentration of 1μg/ml 
and 100μl were added to each well. Plates were incubated for 1 hour at room 
temperature, gently shaking. 
The plates were washed twice in 200μl per well of 1XHSS. Streptavidin-
conjugated liposomes diluted to 50μM phospholipids concentration and 100μl were 
added to each well. Plates were again incubated for 1 hour at room temperature with 
gentle shaking. 
Plates were emptied, dried, and washed three times with 200μl per well 1X 
HSS, respectively. For measuring the fluorescence emission at 590nm, 50μl of 30mM 
octyl-β-D-glucopyranoside (OG) was added to each well. 
 
4.3.5 Concentration and detection of FCV 
 
Prior to performing concentration and detection experiments, the channels of the 
device, shown in Figure 4.1, were primed with 1XHSS. A permanent magnet was 
positioned on the top surface of the device upstream of the detection region using 
adhesive putty. One microliter of polyclonal antibody-conjugated superparamagnetic 
beads was injected towards the magnet through port 5 using a syringe pump at a flow 
rate of 1 µl/min. The packed bead bed at the magnet constitutes the capture region of 
the device. The liposome-antibody conjugate was then mixed with FCV of the 
required concentration and incubated for two hours. This virus-liposome solution was  
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Figure 4.1: Combined Concentration and Detection Device: After the channels are 
filled with 1XHSS and the capture bead bed is packed at the magnet, a virus-liposome 
solution is introduced to port 1 and a potential is applied across the membrane (inset). 
Once concentrated, the virus-liposome bolus is eluted from the membrane by switch-
ing the potential to port 3, downstream of the magnet. Once the sample is captured, 
non-specifically bound liposomes are washed away by wash buffer, applied via port 5 
using pressure-driven flow. Liposomes are then lysed using a detergent introduced 
through the same port. 
 
 
 
 
 
Figure 4.2: Schematic of capture of liposome-virus complex to immobilized magnetic 
bead in the device and the eventual lysis of the liposome upon flowing detergent. 
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loaded into the inlet well of the device while all the other wells were filled with 
1XHSS. The pressure driven flow in the system was eliminated by adjusting the 
heights of the solutions in the wells. The virus-liposome complexes were then 
electrokinetically concentrated at the membrane by applying a voltage difference of 
150V across the membrane. After concentrating for a 90 seconds, the concentrated 
bolus was eluted towards the bead bed by applying a voltage of 150V to the outlet port 
3 downstream of the magnet. This results in the capture of the virus-liposome 
complexes at the bead bed, as illustrated in Figure 4.2. Wash buffer was injected at a 
flow rate of 20 µl/h to wash off any unbound liposomes in the device through port 5. 
A detergent solution of 60mM OG was then introduced through the same port towards 
the bead bed at a flow rate of 40 µl/h and the emitted fluorescence from the lysis of the 
bound liposomes was recorded downstream of the bead bed. Video was captured 
during lysis, and the fluorescent intensity was integrated over time to yield the final 
signal. 
 
4.3.6 Detection of FCV without electrokinetic concentration 
 
To show the effect of pre-concentration on detection of FCV, the assay was also 
carried out in a polydimethylsiloxane (PDMS) microfluidic channel (Figure 4.3), 
fabricated via standard soft lithography techniques, and sealed with an interdigitated 
ultramicroelectrode array (IDUA) fabricated on Pyrex glass, as previously described 
[33]. The assay without electrokinetic concentration is similar to the procedure 
outlined above with several modifications required for the electrochemical transducer 
and pressure-driven flow. Specifically, streptavidin-conjugated liposomes 
encapsulating the ferri/ferrohexacyanide redox couple were substituted for those 
encapsulating SRB. Also, 13µl polyclonal antibody-conjugated superparamagnetic 
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beads were incubated off-chip with the 70µl virus sample for 2 hours, washed 3 times 
in 1XHSS, and final resuspended in 33µl of 1XHSS. These virus-bead complexes 
were then incubated with 60µl of anti-FCV-conjugated liposomes for 1 hour. Of this 
sample, 10 µl were loaded into the device at 5µl/min until the entire sample was 
loaded and the beads captured. The flow was continued for 4 minutes in order to wash 
away any unbound liposomes. As in the case of detection with concentration, 60µM 
OG was injected to lyse the liposomes, here at 1µl/min. 
Though using a different signal transduction method, previous work has shown 
detection limits on the same order of magnitude for fluorescent and electrochemical 
transduction [33].  
 
 
 
 
 
Figure 4.3: Device without pre-concentration module [33]. The device is fabricated by 
bonding PDMS microchannels to a glass wafer patterned with gold interdigitated 
electrodes. The entire device was packaged in a Plexiglas
®
 housing and provided with 
inlet and outlet fluidic connections. 
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4.4 Results and discussion 
 
4.4.1 Selection of antibodies and assay optimization 
 
A series of commercially available and custom antibodies were screened via the 
microtiter plate LIA described and a sample of highly-purified FCV in PBS. It was 
found that many antibody pairs would not result in effective capture and detection of 
FCV. Some pairs generated highly reproducible results and representative data of two 
combinations are shown in Figure 4.4; here antibody pairs employing the polyclonal 
antibody as capture antibody generated high signals and signal-to-noise rations (SNR).  
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Figure 4.4: Dose-response curves for polyclonal capture antibody with monoclonal 
reporter antibodies. The best antibody pair for the detection of FCV was determined 
by screening all variations in a microtiter plate liposome immunoassay (LIA). Here a 
custom polyclonal anti-FCV was immobilized to the plate and biotinylated anti-FCV 
monoclonal antibodies and streptavidin-conjugated fluorescent liposomes were used 
for signal generation. 
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Figure 4.5: Optimized assay for FCV detection in cell culture lysate. Using the pre-
viously optimized antibody pairs, FCV was detected in cell culture lysate consisting of 
DMEM and 10%FBS in a microtiter plate LIA. 
 
 
Based on all combinations tried, it was determined that using a custom polyclonal 
rabbit-derived anti-FCV for capture was best in conjunction with the monoclonal 
labeled “mAb1” (Abcam clone number FCV1-43) as it yielded an SNR just under 9 
for a concentration of 5000 ng/ml. 
Further optimization of the assay employed FCV in lysed cell culture medium, 
containing Dulbecco’s Modified Eagle’s Media (DMEM) with 10% fetal bovine 
serum (FBS), and focused on blocking to reduce non-specific binding. A dose-
response curve was developed for the microtiter LIA for future comparison to 
microfluidic devices, as shown in Figure 4.5. Here, the limit of detection is 
approximately 4x10
4
 PFU/ml (Plaque Forming Units/ml). 
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4.4.2 Comparison of FCV detection with and without electrokinetic concentration 
 
FCV detection experiments were performed to show the improvement in detection 
sensitivity with the inclusion of the electrokientic preconcentration step. In the first set 
of experiments, FCV was detected using the integrated microfluidic device that 
includes the preconcentration step. Fluorescent liposomes were used in these 
experiments and the fluorescence intensity signal from the lysis of the captured 
liposomes was estimated using image processing. These experiemnst were done for 
different concentrations of FCV ranging from 0 – 15 ng/ml (Figure 4.6). The limit of 
detection for these experiments performed with the integrated device was estimated to 
be 4 ng/ml or 1.6 X 10
5
 PFU/ml.   
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Figure 4.6: FCV detection after electrokinetic concentration. FCV samples were incu-
bated with anti-FCV couple liposomes for two-hours at the indicated concentrations. 
Samples were then concentrated for 90sec by application of a potential across a nano-
porous membrane and then eluted to the capture bead bed. After washing, liposomes 
were lysed with detergent and the fluorescence intensity downstream was integrated 
over time. The data is reported as mean ± SD with n=3. * indicates p<0.05.  
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Figure 4.7: FCV detection with direct injection. FCV-magnetic bead complexes were 
incubated with anti-FCV-conjugated-liposomes off-chip and loaded into the device 
using a syringe pump. The captured beads were lysed with detergent and the current 
signal from the released electrochemical markers was quantified. 
 
 
A second set of experiments were performed excluding the preconcentration 
step by directly injecting the virus-liposome-bead complexes towards the magnet. 
Electrochemical liposomes were used in these experiments and the current signal from 
the lysis of the captured liposomes is plotted as a function of the concentration of FCV 
as shown in Figure 4.7. The limit of detection in this case was estimated as 60 ng/ml 
or 2.4 X 10
6
 PFU/ml.   
There is an order-of-magnitude improvement in the limit of detection with the 
integrated microfluidic device over the direct injection system as the increased 
concentration of the analytes improves the antigen-antibody binding kinetics in the 
detection region. The preliminary data for direct injection case was generated by 
incubating the virus sample with the capture beads in suspension of chip, thus 
allowing a greater surface area for capture. Future experiments will use a pre-packed 
bead bed for better comparison.  
 The integrated device can be operated in electrochemical detection mode by 
patterning gold interdigitated electrodes downstream of the detection region and using 
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electrochemical liposomes instead of fluorescent liposomes [33]. The equipment 
needed for electrochemical detection is relatively inexpensive and portable and it can 
also provide quantitative signal read-out [34].  
Current literature reports limits of detection of FCV on the order of 10
6
 
particles/ml using techniques such as Atomic Force Microscopy (AFM) and Surface 
Enhanced Raman Spectroscopy (SERS) [16]. Based on an approximate ratio of 
infectious to non-infectious particles for enteric viruses [35], this corresponds to a 
limit of detection on the order of 10
4
 PFU/ml. Although the limit of detection is lower 
in this case, the equipment required is bulky and expensive. 
Most of the portable microfluidic biosensors for enteric virus detection 
reported in the literature are based on RT-PCR techniques [36-38]. Apart from the 
limitation of PCR inhibitors in environmental water samples, microfluidic PCR 
systems also face the challenges of adsorption of enzymes to channel walls [39], 
difficulty in precisely controlling temperature, sample evaporation and formation of 
bubbles in the channels [40]. The advantage of our integrated microfluidic device is 
that it has on-chip detection times on the order of a few minutes and does not involve 
any temperature cycling issues. 
 
 
4.5 Conclusion 
 
In conclusion, we have shown a limit of detection of 1.6 X 10
5
 PFU/ml for Feline 
Calicivirus using our integrated microfluidic system that combines a membrane-based 
preconcentration system with liposome-based detection. This detection limit is an 
order of magnitude lower than that obtained with a device that does not include 
preconcentration. This device can be extended to operate in electrochemical detection 
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mode by patterning gold electrodes in the device and using electrochemical liposomes. 
Electrochemical detection is inexpensive and portable with quantitative signal readout. 
The on-chip detection time using our microfluidic device is on the order of a few 
minutes. Also, our device has no temperature cycling issues as opposed to 
miniaturized PCR-based devices.  
Future work involves using electrochemical detection with the integrated 
microfluidic device by patterning gold electrodes downstream of the detection region 
in the microfluidic device.  
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CHAPTER 5 
CONCLUSION 
 
 
In this work, we have shown the use of microfluidic control in two different biological 
applications. In the first application, we developed a microfluidic device that has the 
potential to automate combinatorial processes like protein refolding.  This device uses 
pneumatic valves and pumps that can be actuated in an automated fashion to enable 
the process of choosing specific amounts of reagents for mixing. We have also shown 
on-chip assay compatibility for quantifying refolding yields. In the second application, 
we developed an integrated microfluidic device for enteric virus detection in water 
samples. This device integrates membrane-based preconcentration with liposome-
based signal amplification. We used this device for the detection of Feline Calicivirus, 
which is a model system for human enteric virus, in water samples. 
 
 
5.1 Summary of accomplishments 
 
The intended goal for the protein refolding work was to develop a microfluidic device 
that can automate the combinatorial process of finding the right solution conditions to 
properly refold proteins to their native functional state. In Chapter 2, we have 
described in detail our fabrication process for making this two-layered PDMS-on-glass 
device with flow and control channels [1]. The flow of the reagents in the flow 
channels was controlled by pneumatically actuating the control channels. Each flow 
channel was equipped with a valve and a pump to control the choice and amount of 
the reagents injected into the rotary mixer [2]. The pneumatic actuation of the valves 
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and pumps was automated by connecting them to a valve manifold which was 
controlled using a Lab view program. The flow rate of the reagent in the flow channel 
is a function of the actuation frequency of the pump. As the frequency of actuation 
increases, the flow rate also increases initially but at higher frequencies, the flow rate 
decreases due to incomplete valve opening/closing. A frequency of 10 Hz was 
estimated as the optimal frequency for the highest flow rate. By controlling this 
frequency and the time for which the pump is operated, the amount of the reagent 
injected into the rotary mixer can be precisely controlled. We also performed dye-
mixing experiments in the device by injecting two food dyes into the rotary mixer and 
actuating the pump on the mixer. The total time taken for mixing was estimated as 
45s.  Refolding experiments were performed on the protein β-galactosidase and the 
refolding yield was quantified using a fluorometric assay fluorescein di-β-D-
galactopyranoside (FDG) as the substrate [3, 4]. For on-chip quantification of 
refolding yield, different concentrations of β-galactosidase were mixed with FDG and 
the fluorescence intensity of the protein-FDG mixture in a PDMS microchannel was 
estimated using image processing tools to obtain a calibration curve. Multiple 
denaturing and refolding experiments were performed on the protein using optimized 
protocols [5] and using the calibration curve, the active protein content was estimated 
in the denatured and refolded samples. The refolding yields obtained in these trials 
were on the order of 37%, comparable to yields reported in the literature for β-
galactosidase [5]. Since the device is optically clear, it is also compatible with various 
techniques to study refolding intermediates like small-angle x-ray scattering [6] and 
terahertz spectroscopy [7]. 
 The intended goal of the virus detection project was to develop a portable 
inexpensive microfluidic biosensor that can serve as an early screening system for the 
detection of enteric viruses in environmental water samples. This is to overcome the 
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limitations of conventional methods of enteric virus detection like long culture times 
for cell-culture methods and extensive sample preparation requirements for PCR-
based methods [8-10]. In Chapter 3, we describe the design of our integrated 
microfluidic biosensor that combines on-chip preconcentration with liposome-based 
signal amplification. The device was made by etching microchannels in a glass wafer 
and bonding it to another glass wafer using a low-temperature bonding technique [11-
14]. A nanoporous membrane was fabricated at the junction of the microchannels by 
an in situ laser polymerization technique [15-19]. By applying an electric field across 
the membrane, analytes of interest were electrophoretically migrated towards the 
membrane and concentrated by sieving effect. The performance of the membrane was 
characterized by estimating the concentration factors during liposome concentration as 
a function of the time for which an electric field is applied across the membrane. After 
160s of applying an electric field across the membrane, two orders of magnitude 
concentration was obtained in this system. The concentrated bolus of liposomes was 
eluted by switching the electric field towards a detection region downstream. The 
captured liposomes were then lysed by flowing a detergent and released fluorescence 
was quantified.  
 In order to estimate the effect of the preconcentration system on device 
performance, two sets of experiments were performed using biotin-streptavidin 
binding as a model system. In the first set of experiments, biotinylated liposomes were 
electrophoretically concentrated for 90s and eluted towards a bed of streptavidin-
conjugated magnetic beads immobilized at a magnet. In the second set of experiments, 
the biotinylated liposomes were directly injected towards the bead bed without any 
preconcentration. The same number of liposomes was used in both experiments for 
comparison. From these experiments, it was concluded that the inclusion of the 
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preconcentration system results in a fourteen-fold improvement in the signal as 
opposed to a device without preconcentration.  
 In Chapter 4, we used the integrated device for detection of Feline Calicivirus 
(FCV), which is a model system for human enteric virus [20]. FCV was captured in a 
sandwich immunoassay in the device using two sets of antibodies. Protein A beads 
coated with a polyclonal capture antibody and immobilized at the magnet serve as the 
capture region. FCV was tagged to fluorescent liposomes using monoclonal probe 
antibodies off-chip. The antibody pair for the best signals was determined by 
performing microtiter plate assays with different antibody pair combinations. 
Monoclonal probe antibody from Abcam and polyclonal capture antibody was 
determined as the best pair for highest signal-to-noise ratios. On-chip detection 
experiments with the integrated device resulted in a limit of detection (LOD) on the 
order of 1.6 X 10
5
 PFU/ml which was an order of magnitude lower than the LOD 
obtained using a device without preconcentration. The device can be extended to 
operate in electrochemical detection mode, making it an inexpensive and portable 
alternative to existing techniques like AFM and SERS [21]. This technique also does 
not include any temperature cycling issues as opposed to existing microfluidic PCR 
devices [22, 23]. 
  
 
5.2 Future work 
 
Future work for the protein refolding project involves performing on-chip refolding 
assays of β-galactosidase by combinatorially choosing reagents in the three-input 
design. In the off-chip refolding protocol for β-galactosidase, in order to obtain the 
maximum refolding yields, 1mM MgCl2 and 1.4M urea were used in the refolding 
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buffer and the protein was diluted in 1:12 dilution ratio in this buffer [5]. For the initial 
on-chip experiments, the concentrations of these two reagents (MgCl2 and urea) can be 
varied along with the dilution ratio to estimate the optimal conditions for refolding. 
Also, since the refolding protocol involves long incubation times, the device will have 
to be placed in a water bath to prevent evaporation of the reagents from the PDMS 
channels.  
 For the next set of experiments, the number of input channels on the rotary 
mixer in the PDMS –glass device can be increased to include more reagents like 
sodium phosphate and DTE (dithioerythritol). The effect of the individual reagents on 
the refolding yield as well as the effect of a combination of reagents can be evaluated. 
In the current design, each input flow channel is independently controlled by a valve 
and pump to control the choice and amount of reagent being injected into the rotary 
mixer. However, with this configuration, as the system is scaled-up to include more 
input channels, the number of valves and pumps required to control the flow channels 
also scales up linearly. In other words, for n flow channels, the number of control 
channels scales up as 3n (for pumps) + n (for valves). On the other hand, Thorsen et 
al.[24] used combinatorial arrays of binary valve patterns for large-scale integration of 
microfluidic channel networks. For this system, the number of control channels 
required to control n flow channels scales as 2log2n. Thus, only 20 control channels 
are required to control 1024 flow channels. The device design will be changed to such 
a valve pattern to realize large-scale integration with multiple inlet flow channels.  
For the virus detection project, the next step is to extend the device for use in  
electrochemical detection format by patterning gold electrodes downstream from the 
capture region in the device [25]. For these experiments, electrochemical liposomes 
with potassium ferri/ferrohexacyanide molecules will be used for signal amplification 
instead of fluorescent liposomes. These electrochemical markers undergo a cyclic 
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redox reaction at the gold interdigitated electrodes and generate a current signal that 
can be measured using a minipotentiostat. The use of such a minipotentiostat to make 
electrochemical measurements will be explored to show the portability of the 
biosensor [26]. The limiting step in using the device in the electrochemical detection 
mode is the fabrication and integration of the gold interdigitated electrodes in the glass 
device. We chose a low-temperature sol-gel based method for bonding glass wafers 
[12-14] as the conventional high-temperature methods lead to delamination of the 
patterned gold electrodes. However, the extensive pre-cleaning steps for glass wafers 
before bonding have been causing gold delamination issues. This can be overcome by 
improving the adhesion of the patterned gold to glass wafers and also using milder 
pre-cleaning steps before bonding. Different adhesion layers (like Chromium or 
Titanium) and diffusion barriers (like Platinum) can be used to improve the adhesion 
of gold to glass wafers.  
The current limit of detection of our integrated biosensor for Feline Calicivirus 
is 1.6 X 10
5
 PFU/ml. However, environmental water samples contain enteric viruses at 
a much lower concentration (100 PFU/l on an average [8], which translates to about 75 
PFU/ml after using electropositive cartridge filters for concentration, which have 
about 75% recovery efficiency [27-29]). In order to further improve the limit of 
detection of our device, multiple concentration-elution sequences can be performed to 
capture more analytes. Also, the channel layout in the device can be redesigned to 
further decrease the distance between the concentration and detection modules to 
reduce the effects of dispersion. 
In the current protocol for FCV detection using the integrated 
immunobiosensor, FCV is tagged with the liposome-antibody conjugate by incubating 
off-chip for two hours. Although the on-chip detection times using the biosensor are 
much lower compared to other techniques like RT-PCR [30-32], the total analysis time 
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is still high due to the off-chip incubation step. The time for this incubation step can be 
reduced by introducing a mixing region on-chip for tagging FCV with liposome-
antibody conjugate. On-chip mixing can be achieved by using serpentine channels in 
the device.  
Finally, the device will be tested for use with environmental water samples by 
performing control experiments with water spiked with model contaminants. 
Examples of model contaminants that can be used include humic acid, sea salts and 
fine test dust. These contaminants help to identify specific parts of the device that may 
fail upon repeated use. The humic acid has a tendency to adhere to channel walls and 
this tests the effectiveness of the polyacrylamide coating used to prevent adhesion on 
the channel walls. Sea salts increase the conductivity of the buffer and thereby affect 
the electric fields applied in the system during concentration-elution. They may also 
interfere with the current signals during electrochemical detection. The test dust may 
clog the pores of the nanoporous membrane and reduce the concentration efficiency. 
By performing controlled tests with these model contaminants, we can determine the 
level of sample preprocessing needed before it is introduced into the device and also 
get an estimate of the number of times the device can be repeatedly used before it 
fails. 
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